PQM+ is collaborating with several stakeholders in Kenya, including the Pharmacy and Poisons Board (PPB), the National Quality Control Laboratory (NQCL), the Division of National Malaria Control Program, and the Health Products and Technologies Department of the Ministry of Health.
The program provides assistance to improve governance for medical product quality assurance (QA) systems, strengthen regulatory systems for assuring the quality of medical products, and optimize and increase financial resources for medical product QA systems. This includes increasing the capacity of the NQCL to collect fees for quality control testing of antimalarial and reproductive, maternal, newborn, child, and adolescent health products.
In addition, PQM+ works with Kenyan pharmaceutical manufacturers to identify and address challenges related to the local production of essential antimalarial and reproductive, maternal, newborn, child, and adolescent health products to expand medical product availability and increase revenue.
Impact stories and news
- Kenya strengthens surveillance systems
- Kenya among six African countries awarded Global VAX funding
- Ensuring Quality Tools to Fight Malaria
- Risk-based post-marketing surveillance conducted for MCH and antimalaria medicines
- PQM+ supports progress towards compliance of Good manufacturing practices(GMP)
- PQM+ supports NCQLs to optimize financial resources
- Kenya’s Ecumenical Pharmaceutical Network and PQM+ host a webinar on cost perceptions of generic products
Office
Nairobi, Kenya
